Q-omics provides the consensus-scored RAB43P1 profile across patient tissues and cancer cell-line models. RAB43P1 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, RAB43P1 is differentially expressed in 9, with the highest sampling consensus in HNSC. Additionally, RAB43P1 RNA expression shows 18,862 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight UVM, HNSC, and ACC as cancer lineages where RAB43P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RAB43P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RAB43P1 survival associations across molecular data types. RAB43P1 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RAB43P1 RNA expression–survival associations across cancer types. High RAB43P1 expression shows unfavorable associations in LGG, PAAD and KICH, but favorable associations in UVM, KIRC and UCS. The UVM Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .002). Together, the overview and detailed table identify UVM as the clearest survival context for RAB43P1 RNA expression.
This table summarizes RAB43P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for RAB43P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RAB43P1 shows lower tumor expression in KICH, KIRC, KIRP, COAD and THCA and higher tumor expression in HNSC. The HNSC box plot shows higher RAB43P1 RNA expression in tumor versus normal tissue (log2 FC = +1.229, t-test p < 0.001).
This table shows molecular features associated with RAB43P1 in patient tissues and cancer cell lines. In patient samples, RAB43P1 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
